World Drug Safety Congress

Join industry leaders at the World Drug Safety Congress in Amsterdam to explore innovations in pharmacovigilance and connect with experts for regulatory and market entry guidance.

October 7, 2025

Amsterdam, The Netherlands

10:00 AM

Learn more

Event details

The World Drug Safety Congress Europe 2025 will convene over 1,800 key thought leaders on October 7–8, 2025, at the RAI Amsterdam Convention Centre. This premier event focuses on the latest advancements in pharmacovigilance, including the integration of big data and AI, benefit-risk management strategies, and patient-centric approaches. Attendees will explore how innovative technologies are shaping the future of drug safety and impacting patient outcomes.

Critical Findings in GMP Audits How to Identify and Manage Them Effectively

QbD Group, your life sciences partner across the entire product lifecycle

Join QbD Group at booth 34 and discover how we can help you strengthen drug safety, ensure compliance, and accelerate success across the entire product lifecycle.

Innovative support: from early development to post-market surveillance, our team provides end-to-end expertise tailored to your needs.
Expert guidance: speak directly with our specialists in pharmacovigilance, regulatory affairs, and quality to tackle your most pressing challenges.
Industry insights: gain fresh perspectives on evolving drug safety trends and the future of regulatory science.
Global growth: rely on our proven track record to streamline market entry and scale confidently in Europe and beyond.

Meet our experts

Connect with our team of experts

We invite you to meet our team at the World Drug Safety Congress 2025. Whether you’re seeking support in pharmacovigilance, regulatory affairs, or drug safety strategies, QbD Group is here to guide you through the latest developments in the field.

Get in touch with us at WDSC 2025 or contact us today to explore how we can support your journey.

Marin Vrhovac

Business Development Manager - Pharma

Marin Vrhovac is a life sciences business development professional with expertise in regulatory affairs, pharmacovigilance, and quality systems.

He supports pharma and biotech companies across the product lifecycle, building trusted global partnerships and aligning client needs with regulatory and technical solutions.

Susan Veissi

Account Manager

Susan Veissi, PhD, is an Account Manager at QbD Group with a background in nephrology and molecular biology.

She drives business growth across biotech, pharma, and medtech, combining her scientific expertise with a passion for advancing patient care.

Fluent in multiple languages, Susan excels at building client relationships and delivering innovative solutions in healthcare.

Izabela Procino

Senior Business Development Manager Pharma

Izabela Procino is Senior Business Development Manager Pharma at QbD Group, where she supports pharmaceutical companies in navigating complex regulatory environments and bringing safe, effective products to market.

She combines commercial expertise with a strong understanding of the pharma value chain to build lasting client partnerships.